Literature DB >> 10694182

Defensiveness status predicts 3-year incidence of hypertension.

T Rutledge1, W Linden.   

Abstract

OBJECTIVE: A growing body of research indicates that defensive personality styles (in particular, self-deception) may be related to higher resting blood pressure and stress reactivity levels. This study is the first, however, to examine the value of defensiveness as a prognostic indicator for the development of clinical hypertension.
METHODS: Participants were 127 initially normotensive male and female adults who completed a comprehensive protocol including psychological testing, assessment of smoking, physical activity and body fat levels, and 8-12 h ambulatory blood pressure monitoring. Participants returned 3-years later for an identical follow-up protocol. Defensiveness was assessed using the Balanced Inventory of Desirable Responding.
RESULTS: At 3-year testing, 15 of 127 participants (12%) met criteria for hypertension (i.e. ambulatory mean blood pressure > 140/90). Comparisons between defensiveness groups showed that 12 of 60 (20%) high defensiveness participants met hypertension criteria, whereas only three of 67 (4.5%) low defensiveness participants were hypertensive. Logistic regression equations adjusted for age, alcohol usage, bodyfat, self-reported exercise levels, smoking, and year-1 ambulatory blood pressure, revealed that membership in the high defensiveness group was associated with more than a sevenfold risk of 3-year hypertension (adjusted risk ratio, 7.5; 95% confidence interval, 1.5-39.2).
CONCLUSIONS: These findings link defensive characteristics to an increased prospective risk of hypertension using state of the art ambulatory monitoring techniques, and were robust after controlling for established risk factors. We conclude that the current results add to the hypertension literature by demonstrating associations between personality and clinically relevant blood pressure criteria.

Entities:  

Mesh:

Year:  2000        PMID: 10694182     DOI: 10.1097/00004872-200018020-00004

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Defensiveness and individual response stereotypy in asthma.

Authors:  Jonathan M Feldman; Paul M Lehrer; Stuart M Hochron; Gary E Schwartz
Journal:  Psychosom Med       Date:  2002 Mar-Apr       Impact factor: 4.312

2.  Suppressed hostility predicted hypertension incidence among middle-aged men: the normative aging study.

Authors:  Jianping Zhang; Raymond Niaura; John F Todaro; Jeanne M McCaffery; Biing-Jiun Shen; Avron Spiro; Kenneth D Ward
Journal:  J Behav Med       Date:  2005-09-23

3.  High responsivity to threat during the initial stage of perception in repression: a 3 T fMRI study.

Authors:  Victoria Gabriele Paul; Astrid Veronika Rauch; Harald Kugel; Lena Ter Horst; Jochen Bauer; Udo Dannlowski; Patricia Ohrmann; Christian Lindner; Uta-Susan Donges; Anette Kersting; Boris Egloff; Thomas Suslow
Journal:  Soc Cogn Affect Neurosci       Date:  2011-12-01       Impact factor: 3.436

4.  Racial/ethnic and gender differences in the association between self-reported experiences of racial/ethnic discrimination and inflammation in the CARDIA cohort of 4 US communities.

Authors:  Timothy J Cunningham; Teresa E Seeman; Ichiro Kawachi; Steven L Gortmaker; David R Jacobs; Catarina I Kiefe; Lisa F Berkman
Journal:  Soc Sci Med       Date:  2012-05-23       Impact factor: 4.634

5.  Gender-specific association of perceived stress and inhibited breathing pattern.

Authors:  David E Anderson; Margaret A Chesney
Journal:  Int J Behav Med       Date:  2002

6.  Relationship between defenses, personality, and affect during a stress task in normal adolescents.

Authors:  Hans Steiner; Sarah J Erickson; Peggy MacLean; Sanja Medic; Belinda Plattner; Cheryl Koopman
Journal:  Child Psychiatry Hum Dev       Date:  2007-03-14

Review 7.  Repressive/defensive coping, blood pressure, and cardiovascular rehabilitation.

Authors:  Lillian Gleiberman
Journal:  Curr Hypertens Rep       Date:  2007-03       Impact factor: 4.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.